Malin Hultcrantz, Associate Attending Physician, Assistant Professor at MSK Cancer Center, shared on LinkedIn:
“The advancements in myeloma in recent years is truly remarkable!
Excellent summary of treatment updates at the National Comprehensive Cancer Network (NCCN) annual conference by Drs. Kumar, Callander, Faiman, and thank you for the invite to discuss MRD.”
You can also read:
Myeloma Paper of the Day, September 20th, Suggested by Robert Orlowski
